Impact of lifestyle intervention for patients with prostate cancer

Saengryeol Park, Kwangnam Kim, Hyun Kyu Ahn, Jong Won Kim, Gyurang Min, Byung Ha Chung, Kyo Chul Koo

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)


Objectives: Androgen-deprivation therapy (ADT) for prostate cancer (PCa) is associated with reduced physical function and quality of life (QoL). We investigated the impact of a structured lifestyle intervention on the promotion of physical activity (PA) and reduction of sedentary behavior (SB), and its effect on QoL in men on ADT. Methods: Patients with advanced PCa on long-term ADT were randomized to the intervention (N = 11) or a control arm (N = 10) between February 2018 and May 2019. The intervention group received a structured lifestyle intervention including motivational text messages for 8 weeks (maintenance visit at week 12). At each visit, self-report measures and accelerometer data were used to assess PA and SB, and questionnaires were used to measure QoL, life satisfaction, anxiety, and depression. Results: Significantly greater improvements in QoL and depression compared to baseline were reported in the intervention group compared to the control group. In addition, the intervention group also showed a significantly greater increase in self-reported light, as well as moderate-to-vigorous PA, and reduction in self-reported SB. Conclusions: Given its inherent advantage in improving QoL and reducing depression, a lifestyle intervention program should be offered to patients on ADT.

Original languageEnglish
Pages (from-to)90-99
Number of pages10
JournalAmerican Journal of Health Behavior
Issue number1
Publication statusPublished - 2020

Bibliographical note

Publisher Copyright:
© 2020 PNG Publications. All rights reserved.

All Science Journal Classification (ASJC) codes

  • Health(social science)
  • Social Psychology
  • Public Health, Environmental and Occupational Health


Dive into the research topics of 'Impact of lifestyle intervention for patients with prostate cancer'. Together they form a unique fingerprint.

Cite this